NCT03834688
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03834688
Title Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405)
Acronym PrE0405
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors PrECOG, LLC.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field